evidence table

Peppermint Oil Irritable Bowel Syndrome Randomized Trial Evidence Table

Structured evidence table for Peppermint Oil Irritable Bowel Syndrome Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Peppermint Oil Irritable Bowel Syndrome Randomized TrialEvidence from recent systematic reviews and meta-analyses consistently indicates that peppermint oil is the most effective botanical agent, particularly for reducing abdominal pain and overall IBS symptom severity.2Pastras P (2026)Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialThe aim of this review is to summarize, compare, and critically evaluate all plant extracts studied for the prevention and treatment of IBS, integrating mechanistic pathways, clinical evidence, and current international guideline recommendations to clarify their therapeutic relevance for clinical practice.2Pastras P (2026)Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialIrritable Bowel Syndrome (IBS) affects 4-15% of the global population, and the limited efficacy of existing pharmacologic therapies has driven growing interest in plant-based therapeutic options among both patients and clinicians.2Pastras P (2026)Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialA comprehensive assessment of all plant extracts investigated in IBS is therefore essential, given the limited effectiveness of conventional treatments and the increasing interest in complementary approaches.2Pastras P (2026)Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialConclusions Positive diagnosis of IBS-D and an evidence-based, symptom-targeted therapeutic approach are recommended to minimize disease burden.4Ladewski AM (2026)Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialBackground Given their emphasis on holistic, patient-centered care, nurse practitioners (NPs) and physician assistants (PAs) play an increasingly critical role in the care of patients with gastrointestinal conditions, including irritable bowel syndrome (IBS).4Ladewski AM (2026)Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
Peppermint Oil Irritable Bowel Syndrome Randomized TrialObjectives To review key clinical considerations for the diagnosis and management of IBS, focusing on IBS with diarrhea (IBS-D), alongside 2 case presentations.4Ladewski AM (2026)Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimEvidence from recent systematic reviews and meta-analyses consistently indicates that peppermint oil is the most effective botanical agent, particularly for reducing abdominal pain and overall IBS symptom severity.
evidence level2
citationPastras P (2026)
sourcePlant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimThe aim of this review is to summarize, compare, and critically evaluate all plant extracts studied for the prevention and treatment of IBS, integrating mechanistic pathways, clinical evidence, and current international guideline recommendations to clarify their therapeutic relevance for clinical practice.
evidence level2
citationPastras P (2026)
sourcePlant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimIrritable Bowel Syndrome (IBS) affects 4-15% of the global population, and the limited efficacy of existing pharmacologic therapies has driven growing interest in plant-based therapeutic options among both patients and clinicians.
evidence level2
citationPastras P (2026)
sourcePlant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimA comprehensive assessment of all plant extracts investigated in IBS is therefore essential, given the limited effectiveness of conventional treatments and the increasing interest in complementary approaches.
evidence level2
citationPastras P (2026)
sourcePlant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimConclusions Positive diagnosis of IBS-D and an evidence-based, symptom-targeted therapeutic approach are recommended to minimize disease burden.
evidence level4
citationLadewski AM (2026)
sourceDiagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimBackground Given their emphasis on holistic, patient-centered care, nurse practitioners (NPs) and physician assistants (PAs) play an increasingly critical role in the care of patients with gastrointestinal conditions, including irritable bowel syndrome (IBS).
evidence level4
citationLadewski AM (2026)
sourceDiagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
topicPeppermint Oil Irritable Bowel Syndrome Randomized Trial
claimObjectives To review key clinical considerations for the diagnosis and management of IBS, focusing on IBS with diarrhea (IBS-D), alongside 2 case presentations.
evidence level4
citationLadewski AM (2026)
sourceDiagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.

Learn next

Related evidence and supplement guides

GuidePeppermint Irritable Bowel Syndrome Randomized Trial: What the Evidence SaysPeppermint Irritable Bowel Syndrome Randomized Trial has 2 source documents in the current Migak...GuideProbiotics Irritable Bowel Syndrome Meta Analysis: What the Evidence SaysProbiotics Irritable Bowel Syndrome Meta Analysis has 2 source documents in the current Migaku e...GuidePeppermint Oil Functional Dyspepsia Meta-analysis: What the Evidence SaysPeppermint Oil Functional Dyspepsia Meta-analysis has 2 source documents in the current Migaku e...GuidePeppermint Oil Ibs Meta-analysis: What the Evidence SaysPeppermint Oil Ibs Meta-analysis has 2 source documents in the current Migaku evidence database....CompareFish Oil Omega-3 vs Algae Omega-3Both animal and plant sources of omega-3 support heart and brain health, but differ in sustainab...AnswerDoes Probiotics Irritable Bowel Syndrome Meta Analysis work?Probiotics Irritable Bowel Syndrome Meta Analysis has evidence relevant to strength of evidence...AnswerIs Probiotics Irritable Bowel Syndrome Meta Analysis safe?Probiotics Irritable Bowel Syndrome Meta Analysis has evidence relevant to safety, limits, and c...AnswerWhat does the evidence say about Probiotics Irritable Bowel Syndrome Meta Analysis?Probiotics Irritable Bowel Syndrome Meta Analysis has evidence relevant to benefits, uncertainty...

Source documents

  1. Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
  2. Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.